A Phase II Study of Atezolizumab in Combination With Bevacizumab, Carboplatin or Cisplatin, and Pemetrexed for EGFR-mutant Metastatic Non-small Cell Lung Cancer Patients After Failure of EGFR Tyrosine Kinase Inhibitors.
Clinical trial NCT04147351 · COMPLETED
Trial details
- NCT number
- NCT04147351
- Sponsor
- National Taiwan University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-10
- Primary completion
- 2026-02-04
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.